Dexcom’s Stelo glucose biosensor is promoted as a continuous monitor that helps track glucose in the body. What separates it ...

It's not always easy to be a long-term investor, particularly when contending with the natural cyclicality that the stock ...

You don't need to wait for Apple to add glucose sensing to a smartwatch. Biosensors give you real-time data, and you no ...

Oura smart rings will soon be able to help users track their blood sugar levels through a new partnership with Dexcom (DXCM), ...

Uptake of continuous glucose monitoring (CGM) was relatively low among vulnerable diabetes patients in the largest national ...

On Thursday, DexCom Inc (DXCM) stock saw a decline, ending the day at $74.46 which represents a decrease of $-0.78 or -1.04% from the prior close of $75.24. The stock opened at $74.83 and touched a ...

Meredith is joined by professional home painter Nathan Harms to discuss Dexcom for National Diabetes Month.

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” third quarter ...

Managing diabetes is a challenge on its own, but, playing a sport on top of the diagnosis is an even taller task.

Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eighteen analysts that are covering the stock, Marketbeat reports. Six equities ...

A new treatment is changing the lives of those with early onset Type 1 Diabetes. A new drug approved by the Food and Drug Administration in 2022 is the first and only of its kind to delay the onset of ...

National Pension Service raised its holdings in DexCom by 4.1% in the third quarter. National Pension Service now owns ...